OVIT (OncoVista Innovative Therapies) FCF Margin %: 0.00% (As of Sep. 2015)


What is OncoVista Innovative Therapies FCF Margin %?

OncoVista Innovative Therapies OVIT FCF Margin % is 0.00% as of Sep. 2015.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. OncoVista Innovative Therapies's Free Cash Flow for the three months ended in Sep. 2015 was $-0.03 Mil. OncoVista Innovative Therapies's Revenue for the three months ended in Sep. 2015 was $0.00 Mil. Therefore, OncoVista Innovative Therapies's FCF Margin % for the quarter that ended in Sep. 2015 was 0.00%.

As of today, OncoVista Innovative Therapies's current FCF Yield % is 0.00%.

The historical rank and industry rank for OncoVista Innovative Therapies's FCF Margin % or its related term are showing as below:


OVIT's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

OncoVista Innovative Therapies FCF Margin % Related Terms

OncoVista Innovative Therapies FCF Margin % Historical Data

* Premium members only.

The historical data trend for OncoVista Innovative Therapies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoVista Innovative Therapies FCF Margin % Chart

OncoVista Innovative Therapies Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoVista Innovative Therapies Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OVIT vs RSPI, HSTC, CAPS: FCF Margin % Comparison

For the Biotechnology subindustry, OncoVista Innovative Therapies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoVista Innovative Therapies FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoVista Innovative Therapies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where OncoVista Innovative Therapies's FCF Margin % falls into.


OncoVista Innovative Therapies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

OncoVista Innovative Therapies's FCF Margin for the fiscal year that ended in Dec. 2014 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2014 )/Revenue (A: Dec. 2014 )
=-0.232/0
= %

OncoVista Innovative Therapies's FCF Margin for the quarter that ended in Sep. 2015 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2015 )/Revenue (Q: Sep. 2015 )
=-0.027/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
OncoVista Innovative Therapies (OVIT) has a FCF Margin % of 0.00% as of Sep. 2015. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OncoVista Innovative Therapies and its competitors.
Is OncoVista Innovative Therapies' FCF Margin % too high?
OncoVista Innovative Therapies' current FCF Margin % is 0.00%.
How does OncoVista Innovative Therapies' FCF Margin % compare to RSPI and HSTC?
OncoVista Innovative Therapies' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OncoVista Innovative Therapies and its competitors. OncoVista Innovative Therapies's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoVista Innovative Therapies stock overvalued right now?
OncoVista Innovative Therapies (OVIT) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OncoVista Innovative Therapies (OVIT), the current FCF Margin % is 0.00% as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoVista Innovative Therapies Business Description

Address 14785 Omicron Drive, Suite 104, San Antonio, TX, USA, 78245
OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.